C4 Therapeutics CFO Lauren White receives $4.1M in 2021
C4 Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
C4 Therapeutics reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, six executives at C4 Therapeutics received on average a compensation package of $2.7M, a 55% decrease compared to previous year.
Average pay of disclosed executives at C4 Therapeutics
Lauren A. White, Chief Financial Officer, received $4.1M in total. 90% of White's compensation, or $3.7M, was in option awards. White also received $60K in bonus, $103K in non-equity incentive plan, $220K in salary, as well as $6K in other compensation.
Stewart Fisher, Chief Scientific Officer, received a compensation package of $3.8M, which increased by 138% compared to previous year. 82% of the compensation package, or $3.1M, was in option awards.
Adam S. Crystal, Chief Medical Officer, earned $3.6M in 2021, a 122% increase compared to previous year.
Jolie M. Siegel, Chief Legal Officer, received $3.4M in 2021.
Andrew J. Hirsch, Chief Executive Officer, earned $952K in 2021, a 95% decrease compared to previous year.
William T. McKee, Chief Financial Officer, received $348K in 2021, which decreases by 83% compared to 2020.
Related executives
Andrew Hirsch
C4 Therapeutics
Chief Executive Officer
Lauren White
C4 Therapeutics
Chief Financial Officer
William McKee
C4 Therapeutics
Chief Financial Officer
Adam Crystal
C4 Therapeutics
Chief Medical Officer
Stewart Fisher
C4 Therapeutics
Chief Scientific Officer
Jolie Siegel
C4 Therapeutics
Chief Legal Officer
You may also like
Source: SEC filing on April 29, 2022.